Avarra
Avarra uses AI simulations and realistic avatars to help go-to-market teams practice customer conversations and improve their skills.
$17MSeries A
ParticipantDA
Draper Associates
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
Draper Associates is a global venture firm investing in AI, robotics, blockchain, healthcare, biotechnology, aerospace and other emerging technologies.
Its blockchain thesis includes decentralised finance, tokenised assets and decentralised infrastructure. In healthcare, it focuses on technologies such as AI diagnostics, regenerative medicine and neurotechnology that can improve prevention and healthy lifespan.
The firm also backs automation and human-machine collaboration, alongside space technologies. Founders can submit a pitch directly through its website, which also provides an AI pitch-coaching tool.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $101M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionCloverleaf Bio
Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.
$33MSeed
ParticipantPoseidon Aerospace
Poseidon Aerospace is developing unmanned cargo aircraft for commercial freight and defense logistics. Its Egret short-takeoff-and-landing freighter and Heron seaplane are designed to move heavy loads between small, remote or water-based operating sites without an onboard pilot.
$11MSeed
ParticipantAurelius Systems
Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats
$40MSeries A
Role not disclosed